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Abstract Ahighprevalence of asthmahasbeenreportedin athletes.However, studiesinthispopulationusually show
an even higher prevalence of airway hyperresponsiveness (AHR) and exercise-induced bronchoconstriction (EIB).This
reportcompares studiesonself-reportedorphysician-diagnosedasthmain athleteswiththoseusingobjectivemeasures
of airflow limitation or airway responsiveness.The higher prevalence of AHR (or EIB) measured in athletes, when com-
paredwiththeprevalenceof self-reportedorphysician-diagnosedasthma, suggests that abnormalairwayresponses are
commonin athletes, althoughtheyareinfrequentlyassociatedwithtroublesomerespiratorysymptoms.Thismayindicate
underdiagnosis of asthma in athletes, possibly due to an underreporting of respiratory symptoms or a reduction in per-
ceptionofnociceptive sensationswithrepeated exercise over time, oritmay simplymeanthathigh-leveltrainingis asso-
ciated with asymptomatic AHR. In athletes, as in the general population, the use of subjective methods such as surveys
and questionnairesresults in anunderestimation ofthe prevalence of airwaydysfunctionwhen comparedwith objective
measurements.The significance ofthese observationsisunknown, andthere is a needto determinetheir long-term con-
sequences for athletes.r2002 Elsevier Science Ltd.Allrights reserved.
Available online athttp://www.sciencedirect.com
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bronchoconstriction.INTRODUCTION
A growing body of evidence suggests that high-intensity
exercise, done on a regular basis, could contribute to the
development of asthma and/or airway hyperresponsive-
ness (AHR) in athletes (1,2) However, in the studies re-
porting a high prevalence of AHRor air£ow obstruction
in athletes, we observed a general discrepancy between
the number subjects with a diagnosis of asthma and
those showing a signi¢cant fall in forced expiratory vo-
lume in one second (FEV1) after exercise, or a positive
histamine or methacholine challenge test (2^6). Indeed,
the prevalence of self-reported or physician-diagnosed
asthma in athletes is usually much lower than that of
AHR or exercise-induced asthma/bronchoconstriction
(EIA/EIB) (2,17^24). This phenomenon may also be ob-
served in the general population (25), but appear more
accentuated in athletes.
In this report, we reviewed these observations and
compare the published ¢ndings on the prevalence ofReceived 30 January 2002, accepted in revised form 30 September
2002.
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ones of AHR or EIB in athletes.This was done through a
search of theNational LibraryofMedicine database‘‘Pub
Med’’using the following keywords: athletes, prevalence,
exercise-induced asthma or bronchoconstriction, air-
way or bronchial hyperresponsiveness and asthma. No
limited time frame was applied. We only analyzed the
publications written in English who where assessing the
prevalence of asthma or airway response to various
stimuli among athletes. Publications with insu⁄cient de-
scription of the methodology or unclear data were ex-
cluded.We also excluded studies with a total number of
subjects less than 25. Finally, we discuss the possible
causes and implications of these observations.
EVALUATIONOFATHLETES’
PULMONARYFUNCTION
In athletes, as in the generalpublication, respiratory pro-
blems can be evaluated by various methods. Question-
naires and surveys are among the most widely used.
They make it possible to study a large number of indivi-
duals and avoid the taskof recruiting subjects for labora-
tory testing; they also require less time commitment
110 RESPIRATORYMEDICINEfrom busy athletes and are inexpensive. However, the
data collected by these methods may not always accu-
rately re£ect the respiratory condition of the participat-
ing athletes. Indeed, self-reported asthma, physician-
diagnosed asthma and respiratory symptoms, all of
which are frequently recorded in surveys and question-
naires, have the disadvantage of relying on subjective
perception.
Among the objective methods for evaluating the re-
spiratory condition of athletes, the most common is the
change in FEV1 before and after exercise. A criterion
ofZ10% or 15% fall in FEV1 after exercise is often
proposed as a measure of EIB. Although EIB is often
equated with asthma in athletes, it mostly identi¢es a
physiological response to exercise and may not always
correlate well with bronchial response to other triggers
or with respiratory symptoms (26). Methacholine
or histamine challenge tests are also used to de-
termine the degree of AHR in athletes. Although these
objective methods are more demanding than question-
naire-based surveys, they are well standardized and
evaluate more e¡ectively the type andmagnitude of air-
way response.
SUBJECTIVEVS.OBJECTIVE
MEASURESOFABNORMALAIRWAY
RESPONSES INATHLETES
Table1illustrates studies on theprevalence of asthma re-
ported from survey questionnaires, and Table 2, the pre-
valence of AHR or EIB obtained from objective testing.
The criteria used to determine the prevalences of asth-TABLE 1. Self-reported or physician-diagnosed asthma fromqu
Authors (ref.) Year Criteria for asthma
Langdeau et al. (2) 2000 Self-reported or
physician-diagnosed
Weiler and Ryan (17) 2000 Physician-diagnosed
Nystad et al. (18) 2000 Self-reported
Weiler et al. (19) 1998 Physician-diagnosed
Helenius et al. (20) 1997 Physician-diagnosed
Kujala et al. (21) 1996 Physician-diagnosed
Hier and Oseid (22) 1994 Physician-diagnosed
Voy (23) 1986 Physician-diagnosed
Fitch (24) 1984 Physician-diagnosed
Figures in parentheses have been rounded (0^0.4 = 0 and 0.5
prevalence of self-reported or physician-diagnosed asthma r
method.
No, numberof subjects;C(),No control subjects enrolled inth
BAS, basketball; CCS, cross-country skiing; FOT, football,HOC,
ning; MB, mountain-biking; MIS, miscellaneous athletes; SKA, sk
SWI, swimming;T & F, track and ¢eld;TRI; triathlon;WOA,Winte
aPercentage of subjectswith EIA and/or asthma.mawerebasedeither on individual self-reportingof asth-
ma or a diagnosis of asthma previously made by a
physician.When comparing those reported prevalences
of asthma with the measured prevalences of AHR/EIB
found in studies reported inTable 2, one notes a general
discrepancy.Objective measures of AHRwere made (at
rest) either with methacholine or histamine broncho-
provocation. A15 or 20% fall in FEV1at speci¢c provoca-
tion dose (PD15 or PD20) or provocation concentration
(PC20) of methacholine or histamine were used to make
the diagnosis of AHR, as showed inTable 2.The diagnosis
of EIBwas determined from the percentage fall (10,15 or
20%) in expiratory £ows such as FEV1or peakexpiratory
£ow (PEF) after exercise.
InTable 1, although there are variations between the
listed prevalences of self-reported or physician-diag-
nosed asthma in athletes, these prevalences rarely ex-
ceeds the level of 20% of the population studied (2,17^
24). As shown in Table 2, however, the prevalences of
AHR or EIB obtained from objective measurements for
the various study groups are much higher than that ob-
tained fromnon-objectivemeans; generally above the le-
vel of 20% (2^16).This trendis notexclusive to the athlete
population; in the studies (Tables 1 and 2) including con-
trol subjects (either non-athlete or sedentary subjects)
paired for agewith the athlete group, this tendency was
also observed.
Although the identi¢cation of aZ10% fall in FEV1is be-
lieved to bemore sensitive for detection of EIB (Table 2),
studies using this criterion did not always ¢nd a greater
prevalence than studies using the criterion of Z15% or
Z20% fall in FEV1. Furthermore, studies measuring the
prevalence of AHR with the criterion of a 20% fall inestionnaire
Sport (% prevalence) No. athletes/controls
LDR+MB (20)*, SWI (8),
CCS+SKA (28)*,TRI (8),
C (4)
100/50
WOA (22),C () 196
MIS (10),C (7) 1620/1680
SOA (15),C () 699
LDR (17)*, SP (8),C (3) 213/124
MIS (2),C (4) 1282/777
CCS (14)*,C (5) 153/306
SOA (11)a,C () 597
SOA (9),C () 291
^0.9 = 1) to eliminate decimals and represent the percentage
eported by authors, from self-administrated questionnaire
e study.
hockey;HSS,High-school students; LDR, long-distance run-
ating; SOA, Summer Olympic athletes; SP, speed and power;
r Olympic athletes and C; controlgroup.
TABLE 2. Prevalence of AHRor EIB fromobjectivemeasurements
Authors (ref.) Year Method Sport (% prevalence) No. athletes/controls
Langdeau et al. (2) 2000 Methacholine
PC20r16mg/ml
LDR+MB (32),CCS+SKA (52)*
TRI (32),SWI (76)*,C (28)
100/50
Wilber et al. (3) 2000 Z 10% fall FEV1 WOA (23),C () 170
Mannix et al. (4) 1999 Z 10% fall FEV1
a SKA (31),C () 29
Leuppi et al. (5) 1999 Methacholine
PD20r2mg/ml
BAS (21),HOC (35)*,C () 50
Helenius et al. (6) 1998 Histamine
PD15r1.6mg/ml
SP (18),LDR (9), SWI (36)*,
C (11)
162/45
Helenius et al. (7) 1998 Histamine
PD15r1.6mg/ml
SWI (48)*,C (16) 29/19
Schoene et al. (8) 1997 Z 10% fall FEV1 TF (15)
b,C () 189
Potts et al. (9) 1996 Methacholine
PC20r16mg/ml
SWI (60)*,C (13) 35/16
Mannix et al. (10) 1996 Z 10% fall FEV1 SKA (35),C () 124
Provost-Craig et al. (11) 1996 Z 10% fall FEV1
or FEF25^75
SKA (30),C () 100
Sue-Chu et al. (12) 1996 Methacholine
PD20r1800 mg
CCS (23)b,C () 171
Feinstein et al. (13) 1996 Z 15% fall FEV1 FOT (19),C () 48
Feinstein et al. (13) 1996 Z 15% fall PEF FOT (35),C () 48
Brudno et al. (14) 1994 Z 10% fall FEV1 HSS (47),C () 397
Brudno et al. (14) 1994 Z 15% fall FEV1 HSS (31),C () 397
Brudno et al. (14) 1994 Z 20% fall FEV1 HSS (23),C () 397
Pierson and Voy (15) 1988 Z 10% fall PEF SOA (14)b,C () 597
Weiler et al. (16) 1986 Methacholine
PD20r25mg/ml
FOT (50),BAS (25),C (41) 167/167
Figures inparentheseshave beenrounded (0^0.4=0 and 0.5^0.9=1) to eliminate decimals andrepresentthe percentagepre-
valence of AHRor EIB reportedby authors.
No, numberof subjects;C(), no control subjects used in the study.
Methacholine;methacholine challengetest; histamine; histaminechallengetest;FEV1; forcedexpiratory volumein1s;PEF; peak
expiratory £ow;FEF25^75;Forced expiratory £owat 25 and 75% ofthe vital capacity forother abbreviations, refer toTable1.
*Value signi¢cantlydi¡erent (Po0.05) fromthe controlgroup.
aPrevalence of subjects presenting with at least one of the following test:Z10% fall in FEV1, orZ25% fall in PEF, orZ20 fall in
maximummid-expiratory £ow.
bPrevalence generated fromanalysis of authors data.
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or histamine, reported a percent prevalence of AHR
relatively similar to those based on the fall in FEV1 after
exercise. Interestingly, of all sports disciplines presented
in Table 2, swimming shows the highest prevalence
of AHR to agonists such as methacholine or histamine,
ranging from 36 to 76%.
The discrepancy between subjective and objective
assessments of airway dysfunction, however, seems less
marked among Olympians than other categories of ath-
letes. In studies conducted on Summer Games Olympic
athletes, Fitch (24), Voy (23) and Weiler and Ryan (19)
obtained prevalences of 9.3, 11.2 and 15.3%, respectively,
for the diagnosis of asthma, while Pierson and Voy (15)
obtained a 14.2% prevalence from objective measures of
EIB.The same trendcanbe observedin tworecent studies
on Winter Games Olympic athletes (3,17).Weiler andRyan reported that 21.9% of these athletes had a diagnosis
of asthma,whileWilberetal. identi¢edEIB in 23%of them.
There is no obvious explanation for this lack of discre-
pancybetween theprevalences from subjective and objec-
tive assessments among the studies done onOlympic level
athletes. Perhaps, the studies done by Wilberet al. (3) and
Pierson and Voy (15) (Table 2) would have yielded higher
prevalences if AHR to methacholine or histamine had
beenmeasured instead of EIB.The similarity between the
prevalence of physician-diagnosed asthma reported by
Weiler and Ryan (17) and the prevalence of EIB reported
by Wilber et al. (3) could indicate that Winter Olympic
athletes aremore closely followed fordetectionof asthma
than other athletes or that they more accurately per-
ceived their respiratory symptoms. Another explanation
could be that athletes with bothersome respiratory pro-
blems are less likely to advance to the elite level.
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er prevalence of diagnosis of asthma in athletes com-
pared with controls (21). Kujala did a retrospective
study on former male athletes who took part in at least
one international competition between 1920 and 1965.
Among the1282 athletes who were still alive in 1985, 30
(2.4%) mentioned having a history of diagnosed asthma
during the period up to 1985, compared with 27/777
(3.5%) control subjects. These ¢ndings could imply that
the prevalence of asthma increased over the decades
leading up to 1985, that underrecognition of respiratory
disease was more common among these athletes, or
that asthma and AHR either are transient or become
clinically silent over time in athletes.
SUBJECTIVEVS.OBJECTIVE
MEASURESOFABNORMALAIRWAY
RESPONSES INTHENORMAL
POPULATION
A discrepancy between respiratory symptoms and pul-
monary function tests has been frequently documented
(27,28). It may therefore not be surprising that a di¡er-
ence between the prevalence of physician-diagnosed
asthma and objective assessment of AHR has also been
observed in the general population. Chowgule et al. in-
vestigated the population of Bombay and found a 3.5%
prevalence of physician-diagnosed asthma, while the
prevalence of AHRwas17%,with the criteria of a 20% fall
in FEV1 with r2.0mg/ml of methacholine (25). Other
investigators have reported a prevalence of physician-di-
agnosed asthma among the general population of
4.5%^7.2% (29^31).
When we look at the prevalence of AHR, for athletes
as for the general population, objective assessment
methods are more e⁄cient than subjective ones at de-
tecting changes in airway function.Manfreda et al. evalu-
ated adults of the general population in six largeTABLE 3. Possible causes of the discrepancy between phy
in athletes
(1) AHR as an transient and reversible result of a supraph
(2) Presence of asymptomatic AHR (no translation of AH
Minimalvariation of air£owobstruction?
Insu⁄cient airway in£ammation?
Site of airwaychanges (smallvs large airways)?
(3) Under-diagnosis of asthma in athletes?
Poor perception of respiratory symptoms?
Under-reportof symptomsby athletes (interpreted as‘‘normal’’)
Temporal adaptationto nociceptive stimuli?
Under- diagnosis byphysicians (misinterpretation of symptoms, nCanadian cities and found that the prevalence of AHR
tomethacholine ranged from13 to 29% (32). Also, studies
of Trigg et al. and Renwick and Connolly reported a pre-
valence of AHR to methacholine of 23 and 34%, respec-
tively (33,34).
HOWCANWEEXPLAINTHE
VARIATIONINPREVALENCEOF
AIRWAYDYSFUNCTIONIN
ATHLETES?
The discrepancy observed between objective and sub-
jective tests may be the result of various factors, as
shown inTable 3.
Is increased airway response the normal
results of supraphysiologic stimulus?
The increased prevalence of heightened airway re-
sponses to inhaled constrictor agent observed in ath-
letes may not only suggest the presence of an abnormal
condition such as asthma, butcouldbe there£ection of a
normal response to a supraphysiologic stimulus such as
high-intensity exercise. EIB, however, does not seem to
result only from such ‘‘normal’’ response to a ‘‘supranor-
mal’’ stimulus, as it has been shown that airways were
also abnormally responsive to non-physical stimuli such
asmethacholine or histamine. It is possible, as previously
suggestedbyAnderson in a thorough reviewof exercise-
induced asthma, that the humidifying process taking
place in the small airways, in response to exercise, could
lead to airway edema and/ormucus secretion and that in
combination with the ‘‘physiological’’ shortening of
smooth muscles would amplify the airway narrowing
with a resulting reduction in FEV1(35).sician-diagnosed asthma and airway hyperresponsiveness
ysiologic stimulus (intense prolonged exercise)?
R to respiratory symptoms)?
?
o objectivemeasures)?
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asymptomatic airway hyperresponsiveness?
The role of the epithelium in the development of asthma
and AHR has been demonstrated extensively (36). Air-
way epithelium is under major stress during high-inten-
sity exercise. In dogs, it has been shown that repeated
hyperventilation could induce AHR, but also peripheral
airway in£ammation, obstruction, and impaired beta-
agonist-induced relaxation (37).
It would be of interest to determine whether AHR is
associated with airway in£ammation and remodeling in
athletes. In this regard, Helenius et al. observed that the
sputum di¡erential cell counts for eosinophils and neu-
trophils were signi¢cantly higher in a group of swimmers
than in control subjects. He attributed this increase of
in£ammatory cells among swimmers to the long-term
exposure to chlorine derivatives (7). In bronchoalveolar
lavage of healthy subjects, Larsson et al. found an in-
crease in the number of granulocytes and macrophages
after running in cold air (38).There is a need to further
evaluate the presence of airway in£ammatory and struc-
tural changes in di¡erent categories of athletes, particu-
larly in thosewith AHR.
The presence of subjectswith asymptomatic AHRhas
already been documented among the general population
(27,28). At least 20^30%of the subjectswithAHRdonot
report respiratory symptoms compatible with asthma
(27,39). In some subjects this may be a preliminary stage
to the development of asthma; it has in fact been asso-
ciated with airway remodeling and in£ammation, as in
asthma, but to a lesser degree (40).
Furthermore, perception of respiratory symptoms
varies considerably fromone subject to another, as some
individuals are poor perceivers of bronchoconstriction
(41^43). This could certainly apply to athletes as well,
considering thepossible tolerance to nociceptive stimuli,
or temporal adaptation to such symptoms when per-
forming intense physical exercise. We have previously
proposed that subjects doing regular intense exercise
may develop a tolerance to respiratory symptoms (44).
This could partly explain the discrepancy observed in
athletes between self-reported or physician-diagnosed
asthma and the actual presence of AHRor EIB.However,
given the extreme stimuli of drying andcoolingof the air-
ways following intense increase inminuteventilation dur-
ing training, it is surprising to observe so few reported
manifestations in athletes with abnormal airway func-
tion.
It is possible that certain types of sports or training
environments could in£uence the perception of air£ow
obstruction, as we already observed that swimmers
tended to report less breathlessness upon exercise than
athletes training in a cold- or dry-air environment (44).
Based on our previous report (2), in athletes training
mostly in warm/dry-air (such as long-distance runners)and in those training in cold-air (such as cross-country
skiers and speed-skaters), the di¡erence between the
prevalence of subjective and objective assessment was
less pronounced than in triathletes and swimmers. It is
di⁄cult to account for the wide discrepancy between
prevalences obtained from subjective and objective
means in athletes training in indoor pools. It may be re-
lated to the fact that high-intensity training in this parti-
cular type of environment (pools) makes it di⁄cult to
perceive wheezing, breathlessness or phlegm produc-
tion. It could also be hypothesized that regular exposure
to lowdoses of chlorine could alter airway sensorynerve
endings.
Is asthma under-diagnosed in athletes?
The high prevalence of AHR observed in athletes could
also suggest that asthma is underdiagnosed when ques-
tionnaires are used, as they rely on self-report of symp-
toms that could be ignored or not well perceived by
athletes.This phenomenon of underrecognition of asth-
ma can also exist evenwith a physician-made diagnosis of
asthma, as non-specialist physicians rely primarily on re-
spiratory symptoms or treatment trials to make the di-
agnosis of asthma (45).
CONCLUSION
One of the di⁄culties of this analysis is thatmost studies
on physician-diagnosed asthma (Table1) have used a sin-
gle study group composed of mixed sports disciplines.
Consequently, it has not been possible to verify the var-
iations in prevalence of physician-diagnosed asthma
within speci¢c disciplines.
The signi¢cance of the high prevalence of AHR in ath-
letes and its e¡ects on performance are uncertain. In-
creasing e¡orts should be made to better evaluate the
long-term consequences of such features. We believe
that athletes should be educated on the possibility of de-
veloping asthma, as a large number of them are unaware
that they are a¡ected by the condition. Furthermore, to
adequately assess airway function in athletes, particu-
larly in regard to thepotential riskof developing sympto-
matic asthma, objective methods are preferable. A
heavier reliance on such methods could lead to a better
identi¢cation of airway dysfunction in athletes with clin-
ical suspicion of asthma.
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